101160.KQ(101160.KQ)
101160.KQ
No analyst ratings available
No analyst price targets available for 101160.KQ
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $49.30B | $55.20B | $52.60B | $55.20B | $56.00B | $63.90B | $68.30B | $67.80B |
| Low | $49.30B | $55.20B | $52.60B | $55.20B | $56.00B | $63.90B | $68.30B | $67.80B |
| High | $49.30B | $55.20B | $52.60B | $55.20B | $56.00B | $63.90B | $68.30B | $67.80B |
| EBITDA Avg | $13.99B | $15.66B | $14.92B | $15.66B | $15.89B | $18.13B | $19.38B | $19.24B |
| Low | $13.99B | $15.66B | $14.92B | $15.66B | $15.89B | $18.13B | $19.38B | $19.24B |
| High | $13.99B | $15.66B | $14.92B | $15.66B | $15.89B | $18.13B | $19.38B | $19.24B |
| EBIT Avg | $10.77B | $12.06B | $11.49B | $12.06B | $12.24B | $13.96B | $14.92B | $14.81B |
| Low | $10.77B | $12.06B | $11.49B | $12.06B | $12.24B | $13.96B | $14.92B | $14.81B |
| High | $10.77B | $12.06B | $11.49B | $12.06B | $12.24B | $13.96B | $14.92B | $14.81B |
| Net Income Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| EPS Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — |